Impact of tumor cellularity on the HER2 amplification assay by OncoScan in breast cancer. Ohara A, Naoi Y, Shimoda M, Tanei T, et al. Breast Cancer 2021 Feb 16. pii: 10.1007/s12282-021-01226.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ohara A, Naoi Y, Shimoda M, Tanei T, et al. Impact of tumor cellularity on the HER2 amplification assay by OncoScan in breast cancer. Breast Cancer 2021 Feb 16. pii: 10.1007/s12282-021-01226.
PMID: 33591465